pegozafermin

News

Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its phase 3 candidate pegozafermin for MASH.

Oncology

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.